New approach targets cancer stem cells that evade conventional drugs and cause tumours to re-grow . 
  Researchers from Manchester University have developed a new combination of drugs which could overcome this problem . 
  They are testing the drug Sulforadex in the most common type of breast cancer . 
  Cancer that has spread and is incurable kills 1,000 women in Britain every month . 
  ‘Oestrogen receptor’ cancers are currently tackled using hormonal treatments such as tamoxifen . 
 